April 25th 2024
Perry Roy, MD, explains how an FDA-cleared objective test can assist in an ADHD diagnosis.
Prenatal exposure to analgesic opioid linked with elevated risk of ADHD
October 5th 2021A study has found that prenatal analgesic opioid exposure of 5 or more weeks is associated with a slightly elevated risk of attention-deficit/hyperactivity disorder (ADHD) in children compared to exposure of 4 weeks or less.
Hyperactivity, learning disabilities, and social isolation…COVID-19 and its effects on ADHD
October 26th 2020COVID-19 has created many stresses: mental, job-related, and health. For some caregivers, these stressors are complicated further with caring for a child with attention-deficit/hyperactive disorder (ADHD).
Role of relative immaturity in school and ADHD medication use
September 28th 2020Attention-deficit/hyperactivity disorder (ADHD) is marked by age-inappropriate levels of inattention and activity. A report from Finland examines how relative immaturity in the first years of school could increase the risk of ADHD medication use.
FDA permits marketing of device to improve attention function in kids with ADHD
June 17th 2020The US Food and Drug Administration (FDA) permitted marketing for the EndeavorRx, a game-based digital device meant to improve attention function in patients with attention-deficit/hyperactivity disorder (ADHD).
Learning to drive poses extra risks for teens with attention problems
January 8th 2020Teenagers with attention-deficit/hyperactivity disorder (ADHD) or parent-reported “trouble staying focused” are poorer drivers and make more driving errors than their peers during the teenagers’ learning permit period according to recent survey data.
Genetic link ties ADHD risk to maternal age
December 5th 2019A new study reveals that mothers who are aged younger than 20 years when their first child is born were more likely to have a child with attention-deficit/hyperactivity disorder (ADHD), and researchers suggest maternal age and other genetic factors may be the cause.
More support for ADHD and acetaminophen use in pregnancy connection
November 14th 2019For years, researchers have raised concerns about acetaminophen use during pregnancy, now a new study that used cord blood to measure acetaminophen levels at birth links the commonly used medication to later ADHD and autism diagnoses.
6 pitfalls to avoid in managing ADHD
August 7th 2019Attention-deficit/hyperactivity disorder (ADHD) may affect a significant number of children in a pediatric practice. This article reviews diagnostic criteria, comorbidities, and complications of ADHD as well as pitfalls that confront the treating pediatrician.
Is the end of evidence-based guidelines near?
November 26th 2017Dr. Bass’ recent article in Contemporary Pediatrics, “Personalized medicine, right drug, right patient, right time,” provides a miniature but profound view of what may be the future of pediatric healthcare: focusing on healthcare that is truly individualized through precision science in the areas of diagnosis and treatment, rather than generalized, population-based treatment guidelines.
Adverse childhood experiences are linked to ADHD
July 1st 2017Diagnosis of attention-deficit/hyperactivity disorder (ADHD) at age 9 years is associated with adverse childhood experiences (ACEs), according to an analysis of data for 1572 children who are part of the Fragile Families and Child Wellbeing Study (FFCWS) birth cohort.